2013 11:53–9.Ĭordes J, Thünker J, Agelink MW, Arends M, Mobascher A, Wobrock T, et al. Use of repetitive transcranial magnetic stimulation for treatment in psychiatry. Negative symptoms and cognitive impairments in schizophrenia: two key symptoms negatively influencing social functioning. The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Gasquet I, Haro JM, Novick D, Edgell ET, Kennedy L, Lepine JP, et al. Humanistic burden in schizophrenia: a literature review. Millier A, Schmidt U, Angermeyer MC, Chauhan D, Murthy V, Toumi M, et al. Transferability of indirect cost of chronic disease: a systematic review and meta-analysis. 2019 17:25 Predictors of response to rTMS treatment in depression is discussed here. Predictors of response to repetitive transcranial magnetic stimulation in depression: a review of recent updates. The use of repetitive transcranial magnetic stimulation (rTMS) in auditory verbal hallucinations (AVH). Repetitive transcranial magnetic stimulation for hallucination in schizophrenia spectrum disorders: a meta-analysis. Papers of particular interest, published recently, have been highlighted as: Identification of various predictors will guide clinicians in the appropriate selection of rTMS to target auditory hallucinations in schizophrenia. ![]() Various factors predict the response to repetitive transcranial magnetic stimulation in the management of resistant auditory hallucination. Commonly, low-frequency repetitive transcranial magnetic stimulation has been used in the treatment of medication-resistant auditory hallucination. ![]() It is found to be due to abnormal hyperactivity of the neurons at the temporo-parietal junction of dominant hemisphere. Persistent auditory hallucination resistant to pharmacotherapy (antipsychotic treatment) is a therapeutic challenge. Despite adequate pharmacotherapy, a considerable number of patients remain symptomatic, for which brain stimulation (neuromodulation) techniques like electroconvulsive therapy, repetitive transcranial magnetic stimulation and transcranial direct current stimulation are being increasingly used. Antipsychotic medications are the mainstay of treatment in schizophrenia. Schizophrenia is a chronic, highly disabling, severe mental illness. This review aims to discuss the role of repetitive Transcranial Magnetic Stimulation (rTMS) in schizophrenia for the management of persistent auditory hallucination, along with the predictors of response.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |